atropisomeric PI3K beta-selective inhibitor

off-target tox. in higher species, discontinued

from rational design of known starting point

J. Med. Chem., Apr. 15, 2020

Gilead Sciences, Seattle, WA + Foster

Compound (P)-14

“Compound (P)-14″ is a PI3K beta-isoform selective lipid kinase inhibitor. While the compound is potent and has excellent oral PK in higher species, significant irreversible toxicity was observed in a…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: